Treatment of refractory germ cell tumors in children with paclitaxel, ifosfamide, and carboplatin: A report from the Children's Oncology Group AGCT0521 study.

about

Treatment of refractory germ cell tumors in children with paclitaxel, ifosfamide, and carboplatin: A report from the Children's Oncology Group AGCT0521 study.

Item

http://www.wikidata.org/entity/Q52561899

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Treatment of refractory germ c ...... Oncology Group AGCT0521 study.

@en

Treatment of refractory germ c ...... Oncology Group AGCT0521 study.

@nl

type

Item

label

Treatment of refractory germ c ...... Oncology Group AGCT0521 study.

@en

Treatment of refractory germ c ...... Oncology Group AGCT0521 study.

@nl

prefLabel

Treatment of refractory germ c ...... Oncology Group AGCT0521 study.

@en

Treatment of refractory germ c ...... Oncology Group AGCT0521 study.

@nl

P1476

Treatment of refractory germ c ...... Oncology Group AGCT0521 study

@en

P2093

Alberto S Pappo

http://www.w3.org/2001/XMLSchema#string

Caihong Xia

http://www.w3.org/2001/XMLSchema#string

Marcio Malogolowkin

http://www.w3.org/2001/XMLSchema#string

Mark Krailo

http://www.w3.org/2001/XMLSchema#string

Thomas A Olson

http://www.w3.org/2001/XMLSchema#string

P2860

Revised risk classification for pediatric extracranial germ cell tumors based on 25 years of clinical trial data from the United Kingdom and United States.

Is high dose therapy superior to conventional dose therapy as initial treatment for relapsed germ cell tumors? The TIGER Trial.

A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial.

TI-CE high-dose chemotherapy for patients with previously treated germ cell tumors: results and prognostic factor analysis.

High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors.

A review of second-line chemotherapy and prognostic models for disseminated germ cell tumors.

Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy.

UKCCSG's germ cell tumour (GCT) studies: improving outcome for children with malignant extracranial non-gonadal tumours--carboplatin, etoposide, and bleomycin are effective and less toxic than previous regimens. United Kingdom Children's Cancer Stud

Salvage therapy for refractory or recurrent pediatric germ cell tumors: the French SFCE experience.

Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide.

P304

e27111

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PBC.27111

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

A Lindsay Frazier

Carlos Rodriguez-Galindo

Farzana Pashankar

P577

2018-04-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29697191

http://www.w3.org/2001/XMLSchema#string

P932

6019185

http://www.w3.org/2001/XMLSchema#string